FOR IMMEDIATE RELEASE | March 04, 2010
ACS Webinar features tips for using a chemistry degree in finding career opportunities
WASHINGTON, March 4, 2010 — News media and others interested in the chemical sciences are invited to join the next in a series of American Chemical Society (ACS) Webinars, Your Career Matters!, featuring speakers that address a variety of pertinent career topics impacting science and engineering professionals.
Scheduled for Thursday, March 11, 2 – 3 p.m. Eastern Time, the free webinar titled, “Developing Career Skills to Compete in a Global Economy – Observations of AMRI Operations in India, Singapore, Hungary and the United States” will feature Michael Trova, Ph.D., Senior Vice President of Chemistry at AMRI, a global contract research organization (CRO) which provides chemistry and biology services to the pharmaceutical and biotechnology industries.
The ACS Webinar Series connects you with subject experts and global thought leaders in chemical sciences, management, and business to addresses current topics of interest to scientific and engineering professionals. Each webinar includes a 30-minute discussion followed by a Q & A session.
News media and scientists can tune into the conference without charge, but must register for the webinar in advance.
Trova’s topics will include:
- Why scientists and businesses must prepare to be part of an integrated global economy.
- How to seek and participate in new and continuous learning and career development opportunities.
- How to create, mentor, and foster the competencies of those people under your tutelage to enhance their global skill set.
- Strategies to prepare for industrial opportunities in the global chemistry community.
Trova holds global responsibility for AMRI Discovery Chemistry Services in Hungary, Singapore and the United States. In 2004, he led a team that established AMRI’s first international operations in Singapore and Hyderabad, India. AMRI today employs more than 1,300 scientists and support staff globally. Under Trova’s direction, project teams have delivered more than 70 preclinical lead candidates, many of which have progressed to Phase I or Phase II clinical testing. He has published 21 scientific manuscripts and has 21 issued U.S. patents. He received a B.S. degree in chemistry from Rensselaer Polytechnic Institute and a Ph.D. in organic chemistry from the Ohio State University and completed postdoctoral research at the Massachusetts Institute of Technology. Trova is a member of the ACS Organic and Medicinal Chemistry Divisions, the American Association for the Advancement of Science and the New York Academy of Sciences.